1,2-dimethylhydrazine decreases expression ISO RGD:736337 6480464 1, 2-Dimethylhydrazine results in decreased expression of AGXT mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of AGXT mRNA CTD PMID:30723492 17beta-estradiol decreases expression ISO RGD:736336 6480464 Estradiol results in decreased expression of AGXT mRNA CTD PMID:20106945 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:736337 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736337 6480464 Tetrachlorodibenzodioxin results in increased expression of AGXT mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736337 6480464 Tetrachlorodibenzodioxin results in decreased expression of AGXT mRNA CTD PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AGXT mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736336 6480464 Tetrachlorodibenzodioxin results in increased expression of AGXT mRNA CTD PMID:20106945 , PMID:21632981 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of AGXT mRNA CTD PMID:23358152 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of AGXT mRNA CTD PMID:19162173 4-hydroxyphenyl retinamide increases expression ISO RGD:736336 6480464 Fenretinide results in increased expression of AGXT mRNA CTD PMID:16671099 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AGXT mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:736336 6480464 Aflatoxin B1 affects the expression of AGXT protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:736336 6480464 Aflatoxin B1 results in decreased methylation of AGXT exon CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:736336 6480464 Aflatoxin B1 results in decreased expression of AGXT mRNA CTD PMID:21641981 more ... aflatoxin B1 decreases expression ISO RGD:736337 6480464 Aflatoxin B1 results in decreased expression of AGXT mRNA CTD PMID:19770486 Allylamine affects expression EXP 6480464 Allylamine affects the expression of AGXT mRNA CTD PMID:15910882 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AGXT mRNA CTD PMID:16483693 Benoxacor decreases expression ISO RGD:736337 6480464 benoxacor results in decreased expression of AGXT mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO RGD:736336 6480464 Benzo(a)pyrene results in decreased expression of AGXT mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects methylation ISO RGD:736336 6480464 Benzo(a)pyrene affects the methylation of AGXT promoter CTD PMID:27901495 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AGXT mRNA CTD PMID:18164116 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of AGXT mRNA CTD PMID:16648578 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of AGXT gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:736337 6480464 bisphenol A results in increased expression of AGXT mRNA CTD PMID:30245210 bisphenol A affects expression ISO RGD:736336 6480464 bisphenol A affects the expression of AGXT mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AGXT mRNA CTD PMID:30903817 buta-1,3-diene decreases expression ISO RGD:736337 6480464 1, 3-butadiene results in decreased expression of AGXT mRNA CTD PMID:29038090 carbaryl decreases activity EXP 6480464 Carbaryl results in decreased activity of AGXT protein CTD PMID:2119399 CGP 52608 multiple interactions ISO RGD:736336 6480464 CGP 52608 promotes the reaction [RORA protein binds to AGXT gene] CTD PMID:28238834 choline multiple interactions ISO RGD:736337 6480464 [Dietary Fats co-treated with Choline deficiency] results in decreased expression of AGXT mRNA, PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in decreased expression of AGXT mRNA] CTD PMID:29246445 clofibrate multiple interactions ISO RGD:736337 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of AGXT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AGXT mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:736337 6480464 Clofibrate results in decreased expression of AGXT mRNA CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of AGXT mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:736337 6480464 cobaltous chloride results in decreased expression of AGXT mRNA CTD PMID:21139344 copper atom multiple interactions ISO RGD:736336 6480464 [Disulfiram binds to Copper] which results in decreased expression of AGXT mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:736336 6480464 [Disulfiram binds to Copper] which results in decreased expression of AGXT mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:736336 6480464 Copper Sulfate results in decreased expression of AGXT mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:736337 6480464 Cyclosporine results in decreased expression of AGXT mRNA CTD PMID:23830897 cyclosporin A decreases expression ISO RGD:736336 6480464 Cyclosporine results in decreased expression of AGXT mRNA CTD PMID:20106945 more ... diazinon increases methylation ISO RGD:736336 6480464 Diazinon results in increased methylation of AGXT gene CTD PMID:22964155 disulfiram multiple interactions ISO RGD:736336 6480464 [Disulfiram binds to Copper] which results in decreased expression of AGXT mRNA CTD PMID:24690739 doxorubicin increases expression ISO RGD:736337 6480464 Doxorubicin results in increased expression of AGXT mRNA CTD PMID:26873546 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of AGXT mRNA CTD PMID:23962444 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of AGXT mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of AGXT mRNA CTD PMID:24793618 folic acid decreases expression ISO RGD:736337 6480464 Folic Acid results in decreased expression of AGXT mRNA CTD PMID:25629700 fumonisin B1 decreases expression ISO RGD:736337 6480464 fumonisin B1 results in decreased expression of AGXT mRNA CTD PMID:16221962 furan increases methylation EXP 6480464 furan results in increased methylation of AGXT gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of AGXT mRNA CTD PMID:25539665 Heliotrine decreases expression ISO RGD:736336 6480464 heliotrine results in decreased expression of AGXT mRNA CTD PMID:26100227 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of AGXT mRNA CTD PMID:23358152 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of AGXT mRNA CTD PMID:21515302 N-nitrosodiethylamine increases expression ISO RGD:736337 6480464 Diethylnitrosamine results in increased expression of AGXT mRNA CTD PMID:17942915 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of AGXT mRNA CTD PMID:19041683 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AGXT mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AGXT mRNA CTD PMID:18164116 , PMID:28943392 N-nitrosodiethylamine multiple interactions ISO RGD:736337 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of AGXT mRNA, MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AGXT mRNA] CTD PMID:17942915 , PMID:24535843 N-Nitrosopyrrolidine decreases expression ISO RGD:736336 6480464 N-Nitrosopyrrolidine results in decreased expression of AGXT mRNA CTD PMID:32234424 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of AGXT mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:736336 6480464 methyleugenol results in decreased expression of AGXT mRNA CTD PMID:32234424 ozone increases expression EXP 6480464 Ozone results in increased expression of AGXT mRNA CTD PMID:35737395 paracetamol multiple interactions ISO RGD:736337 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of AGXT mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol decreases expression ISO RGD:736337 6480464 Acetaminophen results in decreased expression of AGXT mRNA CTD PMID:29246445 paracetamol decreases expression ISO RGD:736336 6480464 Acetaminophen results in decreased expression of AGXT mRNA CTD PMID:25704631 , PMID:29067470 paracetamol affects expression ISO RGD:736337 6480464 Acetaminophen affects the expression of AGXT mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of AGXT mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO RGD:736336 6480464 perfluorooctanoic acid results in decreased expression of AGXT protein CTD PMID:26879310 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of AGXT protein CTD PMID:34958885 phenformin increases expression EXP 6480464 Phenformin results in increased expression of AGXT mRNA CTD PMID:31324951 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of AGXT mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO RGD:736337 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of AGXT mRNA CTD PMID:24535843 pirinixic acid multiple interactions ISO RGD:736337 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AGXT mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of AGXT mRNA CTD PMID:17164430 , PMID:19162173 pirinixic acid decreases expression ISO RGD:736337 6480464 pirinixic acid results in decreased expression of AGXT mRNA CTD PMID:16221962 pirinixic acid multiple interactions ISO RGD:736336 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AGXT mRNA CTD PMID:19710929 potassium dichromate decreases expression ISO RGD:736337 6480464 Potassium Dichromate results in decreased expression of AGXT mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of AGXT mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:736337 6480464 propiconazole results in decreased expression of AGXT mRNA CTD PMID:21278054 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of AGXT mRNA CTD PMID:23358152 quercetin increases expression ISO RGD:736337 6480464 Quercetin results in increased expression of AGXT mRNA CTD PMID:16455785 quercetin affects expression ISO RGD:736336 6480464 Quercetin affects the expression of AGXT mRNA CTD PMID:21632981 rotenone increases expression EXP 6480464 Rotenone results in increased expression of AGXT mRNA CTD PMID:28374803 senecionine decreases expression ISO RGD:736336 6480464 senecionine results in decreased expression of AGXT mRNA CTD PMID:26100227 Senkirkine decreases expression ISO RGD:736336 6480464 senkirkine results in decreased expression of AGXT mRNA CTD PMID:26100227 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of AGXT protein CTD PMID:29459688 sodium arsenite decreases expression ISO RGD:736336 6480464 sodium arsenite results in decreased expression of AGXT mRNA CTD PMID:29301061 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of AGXT mRNA CTD PMID:21515302 tetrachloromethane decreases expression ISO RGD:736337 6480464 Carbon Tetrachloride results in decreased expression of AGXT mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of AGXT mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of AGXT mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of AGXT mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:736337 6480464 titanium dioxide results in decreased expression of AGXT mRNA CTD PMID:23557971 topiramate increases expression EXP 6480464 topiramate results in increased expression of AGXT mRNA CTD PMID:16979414 trichloroethene increases expression ISO RGD:736337 6480464 Trichloroethylene results in increased expression of AGXT mRNA CTD PMID:19254012 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of AGXT mRNA CTD PMID:30589522 urethane decreases expression ISO RGD:736336 6480464 Urethane results in decreased expression of AGXT mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of AGXT mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:736336 6480464 Valproic Acid results in decreased expression of AGXT mRNA CTD PMID:29154799 , PMID:29501571 zinc atom decreases expression ISO RGD:736336 6480464 Zinc deficiency results in decreased expression of AGXT mRNA CTD PMID:18356318 zinc(0) decreases expression ISO RGD:736336 6480464 Zinc deficiency results in decreased expression of AGXT mRNA CTD PMID:18356318